Cigna reported 11% revenue growth for 2025. Company executives focused on several key issues in its call with investors: its settlement with the Federal Trade Commission, a transformation announced ...
The Federal Trade Commission on Wednesday finalized a major settlement with Cigna Group’s CI pharmacy benefit manager Express ...
Cigna is hoping the settlement it reached with regulators paired with recent legislation will mollify calls to reform PBMs — ...
Cigna (CI) reported fourth quarter earnings that were better than Wall Street was expecting. The Cigna Group president and ...
The Federal Trade Commission has announced what it called a “landmark settlement” with Express Scripts over insulin pricing.
Based on ads released in advance of the Super Bowl, little has changed in the eyes of the pharma industry since the FDA began ...
The agreement announced Wednesday includes sweeping changes to the Cigna PBM’s business practices, including no longer preferring expensive drugs over cheaper equivalents on standard formularies and ...
The Federal Trade Commission has reached a landmark settlement with Express Scripts, one of the nation’s largest pharmacy ...
The Federal Trade Commission announces a settlement agreement with pharmacy benefit manager Express Scripts Inc. a day before ...
Cigna (CI) stock gains as the company beats with Q4 2025 earnings and revenue even as its 2026 earnings outlook trails ...
Cigna Group’s Express Scripts reached a settlement with federal antitrust enforcers to resolve allegations that the company artificially inflated the price of insulin for patients through illegal ...
View Press Release: https://www.ftc.gov/news-events/news/press-releases/2026/02/ftc-secures-landmark-settlement-express-scripts-lower-drug-costs-american-patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results